Results 151 to 160 of about 64,627 (246)

Letter to the Editor Regarding “Differing Impacts of Cardiac Implantable Electronic Device Leads on Tricuspid Regurgitation”

Journal of Arrhythmia
Syed Sardar Shah, Ziad Khan, Attiq Ur Rehman, Shah Nawaz, Saleem Jan   +4 more
doaj   +1 more source

Wide QRS Complex Tachycardia in a Patient With Acute Myocarditis Temporarily Protected With a Wearable Cardioverter-Defibrillator. [PDF]

Cureus
Wojtaszczyk A, Wranicz JK, Cygankiewicz I, Kaczmarek K.   +3 more
europepmc   +1 more source

A Case Series of Sudden Death in Children Aged 12 Months to 4 Years From LPIN1 Deficiency and PPA2 Deficiency in Queensland

Journal of Paediatrics and Child Health, EarlyView.
Sophie Manoy, Sally Smith, Marita Smith, Catherine Atthow, Janette Spicer, Matthew Lynch, Michelle Lipke, Julie A. McEniery, David Coman, Anita Inwood, Jim McGill, Carolyn Bursle   +11 more
wiley   +1 more source

A Reassessment of Prophylactic Antibiotics in Low‐Infection‐Risk Electrophysiology Procedures

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Certain electrophysiology (EP) procedures are associated with minimal tissue disruption and do not involve permanent transvenous leads. As a result, these interventions carry a lower risk of device‐ or procedure‐related infection. These procedures include placement of implantable cardiac monitors, leadless pacemakers, and left atrial appendage
Rahel M. Sileshi, Katherine Mathes, Sathya Kosuri, Amulya Gupta, Neil Phillips, Rhea Pimentel, Martin Emert, Siva Soma, Rigoberto Ramirez, Raghuveer Dendi, Madhu Reddy, Seth H. Sheldon, Wissam El Atrouni, Larry M. Baddour, Amit Noheria   +14 more
wiley   +1 more source

Superior vena cava isolation with pulsed field ablation in the presence of defibrillator leads

Journal of Arrhythmia, 2023
Dimitrios Tsiachris, Ioannis Doundoulakis, Athanasios Kordalis, Christos‐Konstantinos Antoniou, Konstantinos Tsioufis   +4 more
doaj   +1 more source

Extravascular implantable cardioverter-defibrillator implantation strategies following transvenous or subcutaneous device infections: a case series. [PDF]

Eur Heart J Case Rep
Ono S, Oka S, Wada M, Ishibashi K, Wakamiya A, Ueda N, Nakasuka K, Kusano K.   +7 more
europepmc   +1 more source

Safety of Pulsed Field Ablation: Established Evidence, Emerging Risks, and Knowledge Gaps

Pacing and Clinical Electrophysiology, EarlyView.
Overview of the safety profile of pulsed field ablation (PFA), highlighting established safety advantages, procedure‐related complications, electroporation‐specific effects, and key areas of ongoing uncertainty, particularly for ventricular applications.
Dakota de Cecco, Jeanne du Fay de Lavallaz, Boldizsar Kovacs, Jackson J. Liang   +3 more
wiley   +1 more source

Implantable cardioverter – defibrillators in patients with suboptimal neurological status

Hellenic Journal of Cardiology, 2020
Konstantinos A. Gatzoulis, Polychronis Dilaveris, Christos-Konstantinos Antoniou, Anastasia Damelou, Dimitrios Tousoulis   +4 more
doaj   +1 more source

Single-Pocket-Incision Generator Exchange From a Subcutaneous to an Extravascular Implantable Cardioverter-Defibrillator. [PDF]

J Arrhythm
Onishi Y, Chino S, Kurata M, Iso Y, Suzuki H.   +4 more
europepmc   +1 more source

Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes

The Journal of Physiology, EarlyView.
Abstract figure legend Most genes involved in inherited primary arrhythmia syndromes (IPAS) are conserved in Caenorhabditis elegans, where genetic manipulation enables functional characterization of variants, identification of regulatory proteins, and in vivo drug testing.
Antoine Delinière, Thomas Boulin, Maëlle Jospin, Alexandre Janin, Gilles Millat, Philippe Chevalier, Olga Andrini   +6 more
wiley   +1 more source